Medisize Corporation, a leading player in the medical device industry, is headquartered in Finland (FI) and operates extensively across Europe and North America. Founded in 1985, the company has established itself as a pioneer in the design and manufacturing of innovative medical solutions, particularly in the fields of drug delivery and diagnostic devices. Medisize is renowned for its commitment to quality and precision, offering a diverse range of core products, including injection moulded components and advanced delivery systems. What sets Medisize apart is its focus on customisation and collaboration with clients to develop tailored solutions that meet specific healthcare needs. With a strong market position, Medisize has achieved notable milestones, including certifications for quality management systems and partnerships with leading pharmaceutical companies, solidifying its reputation as a trusted provider in the medical technology sector.
How does Medisize Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Rubber and Plastic Products industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Medisize Corporation's score of 25 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medisize Corporation, headquartered in Finland (FI), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Koch Industries, LLC, which may influence its climate commitments and performance metrics. As of now, Medisize Corporation has not established any documented reduction targets or initiatives related to carbon emissions. The absence of specific emissions data suggests that the company may be in the early stages of developing its climate strategy or reporting framework. Emissions data may be inherited from its parent company, with relevant performance metrics potentially cascading from Koch Industries, LLC. However, no specific figures or targets have been disclosed at this level either. In summary, while Medisize Corporation is part of a larger corporate family that may have climate commitments, it currently lacks detailed emissions data and defined reduction initiatives. The company may benefit from aligning its strategies with industry standards and best practices to enhance its sustainability profile.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medisize Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.